Financial Guidance and Company Overview

Established U.S. Commercial Footprint Drives Near-Term Revenue Growth with Business Development Opportunity for Future Growth • • • Focus R XYOSTED Ⓡ TLANDO™M NOCDURNA Ⓡ Sales Force 108 representatives • 12 regional managers 2 area directors Targeting • • 16,000 urologists, endocrinologists and primary care physicians 95% top 3 decile testosterone prescribers covered Business development for future growth Urology Endocrinology Antares Corporate Presentation March 2022 95 Halozyme 12 O

View entire presentation